Tag: CSL
CSL opens new manufacturing facility in Broadmeadows
Leading biotherapeutics company CSL Limited has officially opened a new $230 million advanced manufacturing facility in Melbourne's north,
Located at its Behring site in Broadmeadows,...
CSL to buy majority stake in a leading Chinese plasma fractionator
Australian biotech firm CSL has agreed to acquire an 80% stake in China’s plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (Ruide) in...
CSL workers demand “fair share” of massive profit
More than 200 CSL workers and AMWU members gathered outside the main Victorian plant on Tuesday to protest against the company’s decision to cut...
CSL completes acquisition of Novartis flu division
Australian pharmaceutical giant CSL has completed the US $275 million acquisition of Novartis' influenza business.
The transaction will see CSL combine the influenza vaccines division with its...
Aussie Vistaprint wins “Nobel Prize of Manufacturing”
Jim Glover of Complete Lean Solutions (CLS) collected a Shingo Award – the Nobel Prize of Manufacturing – on behalf of Victorian printers Vistaprint...
CSL urges Federal Government to introduce “advanced manufacturing tax”
Australia’s largest biotechnology company, CSL, has urged the Federal Government to consider a more competitive corporate tax environment, such as an advanced manufacturing tax...
CSL acquires Novartis flu division
CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational...
New CSL facility to fight bleeding disorders
CSL Limited has officially opened the CSL Behring Biotechnology Manufacturing Facility in Broadmeadows, Melbourne, which is expected to play a key role in the company’s...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
